Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Studying the Expected Effect of Ivermectin Nanosuspension as Nasal Spray Upon Post covid19 Persistant Anosmia

NCT04951362 is registered in ClinicalTrials.gov with South Valley University as lead sponsor.

NCT NCT04951362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04951362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Studying the Expected Effect of Ivermectin Nanosuspension as Nasal Spray Upon Post covid19 Persistant Anosmia
Lead sponsor
South Valley University
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 20, 2021
Completion date
May 15, 2022
Enrollment
117 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anosmia